A study conducted in a mouse model of pancreatic ductal adenocarcinoma found particularly high levels of neutrophils expressing C-C chemokine receptor type 2 (CCR2) in the brain of mice early in the disease development. This evidence concerns the gene CCR2 and pancreatic ductal adenocarcinoma.